Draper’s Millions: The Philanthropic Wellspring of Modern Race Science
By Angela Saini,
Undark
| 12. 16. 2022
In 1961, a new journal of ethnology and anthropology appeared on academic bookshelves. Nearly every page betrayed an obsession with racial differences.
“The few worthwhile contributions cannot justify the publication of the rest of the journal,” wrote the English anthropologist G. Ainsworth Harrison, spotting error after error. “None of the authors rigorously and objectively appraises the limitations of the tests he uses.” One article made the bizarre claim that Egypt — a country described as being made up of racial “hybrids” — was more “disease-ridden” as a result. “What is particularly insidious in a supposedly scientific journal is the use of words with overtones of moral judgment,” Harrison concluded.
What he didn’t know was that this was entirely by design. The journal had been founded by a tight web of far-right thinkers intent on blocking racial integration in the United States, ending immigration from everywhere but Western Europe, and promoting eugenic policies that would encourage only those they believed were the fittest to survive and reproduce. They were relying on the naivete of fellow researchers, using academia as cover so...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...